Dmitry Balyasny’s PetMed Express PETS Stock Holding History

Dmitry Balyasny’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-82,944	Closed	-$1.35M	–	2665
2023 Q1	$1.35M	Buy	+82,944	New	+$1.56M	﹤0.01%	1628
2020 Q3	–	Sell	-5,807	Closed	-$207K	–	1521
2020 Q2	$207K	Sell	5,807 -159,992	-96%	-$5.56M	﹤0.01%	1041
2020 Q1	$4.77M	Buy	+165,799	New	+$4.35M	0.06%	422
2019 Q2	–	Sell	-16,481	Closed	-$375K	–	1674
2019 Q1	$375K	Buy	+16,481	New	+$372K	﹤0.01%	1259
2018 Q4	–	Sell	-73,993	Closed	-$2.44M	–	1663
2018 Q3	$2.44M	Buy	73,993 +26,086	+54%	+$975K	0.01%	920
2018 Q2	$2.11M	Sell	47,907 -86	-0.2%	-$3.33K	0.01%	920
2018 Q1	$2M	Buy	+47,993	New	+$2.22M	0.01%	995
2017 Q4	–	Sell	-64,717	Closed	-$2.15M	–	2242
2017 Q3	$2.15M	Buy	+64,717	New	+$2.63M	0.01%	943

Other funds holding PETS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

SCM

SG Capital Management Chicago, Illinois $1.21B AUM 70.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dmitry Balyasny's PETS Position: Q2 2023 in Review

Dmitry Balyasny sold out of PetMed Express (PETS) in Q2 2023, closing a stake of 82,944 shares — an estimated $1.35M sold.

Dmitry Balyasny first reported a position in PETS in Q3 2017 and held it in 8 quarters. The position peaked at $4.77M in Q1 2020. 149 funds tracked by Wall St. Rank hold PETS as of Q2 2023.

Dmitry Balyasny reported no remaining PetMed Express position as of Q2 2023 after selling out during the quarter.
Dmitry Balyasny sold 82,944 PetMed Express shares in Q2 2023, an estimated $1.35M.
Dmitry Balyasny first reported a position in PetMed Express in Q3 2017 and held it in 8 quarters.
Dmitry Balyasny's PetMed Express position peaked at $4.77M in Q1 2020.
149 funds tracked by Wall St. Rank held PetMed Express as of Q2 2023.

Based on Balyasny Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.